Posts by VIVA! Communications
World Diabetes Day 2023
To mark World Diabetes Day today (Tuesday, November 14, 2023), VIVA! Communications wishes to shine a light on the often overlooked, misunderstood &/or stigmatised experiences witnessed by children & teens living with juvenile (Type 1) diabetes, & their families, community supporters & healthcare providers. T1D is a lifelong, & potentially devastating disease, for which…
Read MoreHealth Industry Hub Catalysts for Change Awards 2023 ‘PR Agency Individual of the Year’
VIVA! Communications wishes to extend congratulations to our agency Principal, Kirsten Bruce, for winning the inaugural Health Industry Hub Catalysts for Change Awards 2023 ‘PR Agency Individual of the Year’ held at Cockle Bay Wharf, Darling Harbour last night (November 1, 2023). Celebrating the best of the best in the Australian health, pharma, medtech, biotech & diagnostics sectors, the Catalysts…
Read MoreCelebrating 30 years of the ‘JDRF One Walk’ for Type 1 diabetes
This October 2023, the Juvenile Diabetes Foundation (JDRF) is celebrating 30 years of running the JDRF local One Walk. Striving to achieve a world free from Type 1 diabetes (T1D) courtesy of crucial, life-changing research, the JDRF One Walk event provides invaluable support to the T1D community, including the more than 130,000 Australians living with…
Read MoreGlobal Health Marketing and Communications (GHMC) welcomes Improve Comunicaciones as an exclusive agency partner in Mexico, strengthening network’s capabilities in Latin America
As the exclusive Australian partner of Global Health Marketing and Communications (GHMC) – the largest and most robust network of independent healthcare agencies worldwide – VIVA! Communications extends a warm welcome to our newest member – Improve Comunicaciones. The addition of the Mexican-based, strategic consulting agency to GHMC, strengthens our GHMC network’s offering, and capabilities…
Read MoreNew treatment now PBS listed for Australians living with chronic plaque psoriasis
The October 1, 2023 Pharmaceutical Benefits Scheme (PBS) listing of a new, once-daily, oral treatment for severe chronic plaque psoriasis represents good news for the estimated 19,000 Australian adults living with the common inflammatory skin disease. At VIVA! Communications, we are proud to be supporting the communication of this PBS listing announcement, working in partnership…
Read More